| Financial Year |
March 31 2023 |
| Monetary Funds |
651,932,480.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
250,286,357.03 |
| Accounts Receivable |
581,080,020.89 |
| Advances to Suppliers |
32,448,072.66 |
| Other Receivables |
13,740,438.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
635,550,816.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,954,608.71 |
| Total Current Assets |
2,170,895,320.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
271,556,159.06 |
| Under-construction Projects |
15,406,572.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,870,547.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,260,407.43 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
310,479,762.57 |
| Total Assets |
2,481,375,083.02 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
339,302,931.93 |
| Accounts Payable |
411,512,064.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
-- |
| Taxes Payable |
7,918,665.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
109,295,911.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,543,807.14 |
| Other Current Liabilities |
1,765,571.18 |
| Sub-Total of Current Liabilities |
937,833,814.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
988,760.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
49,036,452.40 |
| Total Liabilities |
986,870,266.56 |
| Paid-In Capital(Or Share Stock) |
274,959,040.00 |
| Capital Surplus |
448,073,674.07 |
| Surplus Reserve |
107,972,394.09 |
| LESS:Treasury Stock |
60,699,955.20 |
| Undistributed Profits |
724,199,663.50 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,494,504,816.46 |
| Owner's Equity（Stockholder's Equity） |
1,494,504,816.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,481,375,083.02 |
